Prognostic value and link to atrial fibrillation of soluble klotho and FGF23 in hemodialysis patients

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Nowak, Albina ^a   Friedrich, Björn ^b,c   Artunc, Ferruh ^b   Serra, Andreas L ^a   Breidthardt, Tobias ^d   Twerenbold, Raphael ^d   Peter, Myriam ^d   Mueller, Christian ^d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Dialysis Center   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; SOLUBLE KLOTHO PROTEIN; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SURVIVAL; TREATMENT OUTCOME; ATRIAL FIBRILLATION; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL RATE;

EID: 84903793243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100688     Document Type: Article

References (41)

1. Shroff GR, Frederick PD, Herzog CA (2012) Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J 163: 399-406.
2. Quarles LD (2008) Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118: 3820-3828.
3. Drueke TB (2010) Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation? Kidney Int 78: 1057-1060.
4. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774. (Pubitemid 44949607)
5. Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, et al. (2004) Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett 565: 143-147. (Pubitemid 38595335)
6. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, et al. (2012) Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125: 2243-2255.
7. Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, et al. (2013) A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One 8: e56695.
8. Maekawa Y, Ishikawa K, Yasuda O, Oguro R, Hanasaki H, et al. (2009) Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35: 341-346.
9. Moe SM, Radcliffe JS, White KE, Gattone VH, 2nd, Seifert MF, et al. (2011) The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. J Bone Miner Res 26: 2672-2681.
10. Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, et al. (2012) Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant.
11. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51. (Pubitemid 27494749)
12. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592.
13. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, et al. (2011) FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22: 1913-1922.
14. Isakova T, Xie H, Yang W, Xie D, Anderson AH, et al. (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305: 2432-2439.
15. Seiler S, Cremers B, Rebling NM, Hornof F, Jeken J, et al. (2011) The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J 32: 2688-2696.
16. Huang CL (2010) Regulation of ion channels by secreted Klotho: mechanisms and implications. Kidney Int 77: 855-860.
17. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, et al. (2006) TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 116: 3114-3126. (Pubitemid 44878626)
18. Xie J, Cha SK, An SW, Kuro OM, Birnbaumer L, et al. (2012) Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun 3: 1238.
19. Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, et al. (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109: 1776-1782. (Pubitemid 38500681)
20. Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, et al. (2012) Sensitive troponins-which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One 7: e47610.
21. Artunc F, Mueller C, Breidthardt T, Twerenbold R, Rettig I, et al. (2012) Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker? Kidney Blood Press Res 36: 172-181.
22. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, et al. (2010) Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 398: 513-518.
23. Seiler S, Wen M, Roth HJ, Fehrenz M, Flugge F, et al. (2013) Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 83: 121-128.
24. Anour R, Andrukhova O, Ritter E, Zeitz U, Erben RG (2012) Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo. PLoS One 7: e31376.
25. Komaba H, Koizumi M, Tanaka H, Takahashi H, Sawada K, et al. (2012) Effects of cinacalcet treatment on serum soluble Klotho levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 27: 1967-1969.
26. Akimoto T, Shiizaki K, Sugase T, Watanabe Y, Yoshizawa H, et al. (2012) The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. Clin Exp Nephrol 16: 442-447.
27. Tangri N, Alam A, Wooten EC, Huggins GS (2011) Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort. Nephrol Dial Transplant 26: 3998-4002.
28. Gutierrez OM, Wolf M, Taylor EN (2011) Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol 6: 2871-2878.
29. Tandon T, Sinha AD, Agarwal R (2013) Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure. Nephrol Dial Transplant 28: 1562-1568.
30. Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K, et al. (2013) Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Nephrol Dial Transplant.
31. Smith ER, McMahon LP, Holt SG (2013) Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs. Clin Chem Lab Med 51: 1971-1981.
32. Six I, Okazaki H, Gross P, Cagnard J, Boudot C, et al. (2014) Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium. PLoS One 9: e93423.
33. Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BC, et al. (2009) Klotho prevents renal calcium loss. J Am Soc Nephrol 20: 2371-2379.
34. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, et al. (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308: 1801-1804. (Pubitemid 40848011)
35. Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, et al. (2013) Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 28: 352-359.
36. Etter C, Straub Y, Hersberger M, Raz HR, Kistler T, et al. (2010) Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis. Eur Heart J 31: 354-359.
37. Trivedi H, Xiang Q, Klein JP (2009) Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant 24: 258-266.
38. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, et al. (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740. (Pubitemid 37098542)
39. Tong LL, Mehrotra R, Shavelle DM, Budoff M, Adler S (2008) Poor correlation between coronary artery calcification and obstructive coronary artery disease in an end-stage renal disease patient. Hemodial Int 12: 16-22. (Pubitemid 351247371)
40. Yoshida H, Yokoyama K, Yaginuma T, Ohkido I, Yamamoto H, et al. (2011) Difference in coronary artery intima and media calcification in autopsied patients with chronic kidney disease. Clin Nephrol 75: 1-7.
41. Heijboer AC, Blankenstein MA, Hoenderop J, de Borst MH, Vervloet MG (2013) Laboratory aspects of circulating alpha-Klotho. Nephrol Dial Transplant.